Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17e3793ef4dc05544df3e105e7b778a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e07c0fc376da62ef2ba6f66c7812632c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ebe7395afef3b8482bbab598139d18c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ebd29f4e9ce7b8a80e43004b3a6f639 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9785eeee3573a248195745268fa9198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ca5d7680dc72870c22144f5a554aca |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N57-10 |
filingDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889df740cacb160e7b5312fb642366a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84fcb24dbc3d795e2345ee3220c621e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146c90bd046fb90bee773e5ffade3f93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464046ed74b1ec4b2b9c1360121c4d35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b7c5885212af8f15cee34063ffc314 |
publicationDate |
2012-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8158139-B2 |
titleOfInvention |
Topical gel formulation comprising organophosphate insecticide and preparation thereof |
abstract |
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022167359-A1 |
priorityDate |
2004-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |